A REVIEW OF OZEMPIC’S OFF LABEL USE FOR WEIGHT LOSS IN NON-DIABETIC INDIVIDUALS: CLINICAL EVIDENCE, SAFETY AND ETHICS. Biosci. Insights. 2026;3(3):48-53. Accessed November 13, 2026. https://www.biosciinsights.com/index.php/BI/article/view/188